Mijatovic, S <br/><br/>
Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin.  [electronic resource] 

 -  Cellular and molecular life sciences : CMLS  Jun 2005 
 - 1275-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1420-682X 
<br/><br/><label>Standard No.: </label>10.1007/s00018-005-5041-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthraquinones<br/>Antineoplastic Agents--antagonists & inhibitors<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cisplatin--antagonists & inhibitors<br/>Dose-Response Relationship, Drug<br/>Drug Antagonism<br/>Emodin--pharmacology<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Fibrosarcoma--drug therapy<br/>Flavonoids--pharmacology<br/>Glioma--drug therapy<br/>Mice<br/>Platinum--chemistry<br/>Rats<br/>Structure-Activity Relationship